Clinical Evaluation of the RH210 Hearing Aid Software Used With RH210A Device in Adults With Perceived Mild-to-Moderate Hearing Loss
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age 18 years
• Self-perceived mild-to-moderate hearing difficulties/ hearing loss
• Competent smartphone use (able to complete self-fitting via the app)
• Able and willing to provide informed consent
• HHIA screening consistent with perceived hearing difficulty
• Willingness and ability to attend two in-person research appointments
• Ability to operate a SmartPhone
Locations
Other Locations
Australia
National Acoustic Laboratories
RECRUITING
Macquarie Park
Contact Information
Primary
Marisa Poulos, Master of Audiology
marisa.poulos@nal.gov.au
+61 2 9412 6872
Backup
Sanna Hou, Master of Audiology
sann.hou@nal.gov.au
+61 2 9412 6872
Time Frame
Start Date: 2026-04-11
Estimated Completion Date: 2026-08-30
Participants
Target number of participants: 24
Treatments
Other: All participants
Trial device assessment in first appointment, comparator in second appointment
Other: All Participants
Comparator in appointment one, trial device in appointment 2
Related Therapeutic Areas
Sponsors
Collaborators: National Acoustic Laboratories, Global Edge Medtech Consulting
Leads: Rehear Audiology Company LTD